| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal inhibitory synapse morphology | 5.99e-05 | 8 | 21 | 2 | MP:0020358 | |
| Domain | SAM_DOMAIN | 5.53e-03 | 95 | 22 | 2 | PS50105 | |
| Domain | SAM/pointed | 8.28e-03 | 117 | 22 | 2 | IPR013761 | |
| Pubmed | 1.64e-05 | 9 | 24 | 2 | 14660436 | ||
| Pubmed | Junctophilin-2 is necessary for T-tubule maturation during mouse heart development. | 3.00e-05 | 12 | 24 | 2 | 23715556 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.20e-04 | 440 | 24 | 4 | 34244565 | |
| Pubmed | 2.31e-04 | 446 | 24 | 4 | 24255178 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.55e-04 | 180 | 24 | 3 | 35198878 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 2.98e-04 | 190 | 24 | 3 | 15161933 | |
| Pubmed | 3.03e-04 | 191 | 24 | 3 | 31177093 | ||
| Pubmed | 3.41e-04 | 1431 | 24 | 6 | 37142655 | ||
| Pubmed | 4.42e-04 | 529 | 24 | 4 | 14621295 | ||
| ToppCell | Parenchymal-10x3prime_v2-Hematologic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.12e-05 | 25 | 24 | 2 | 7b267cdcb6afcf603d566c4d5268eb44eacf47b6 | |
| ToppCell | Parenchymal-10x3prime_v2-Hematologic-Erythrocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.12e-05 | 25 | 24 | 2 | 096ca30d9277cfd9cb2501c40b085cc358cb628b | |
| ToppCell | Parenchymal-10x3prime_v2-Hematologic-Erythrocyte-Erythrocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.12e-05 | 25 | 24 | 2 | 3d7b43ecf6ae64996d91765c50f614742e18bd25 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 159 | 24 | 3 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 159 | 24 | 3 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-05 | 162 | 24 | 3 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.12e-04 | 176 | 24 | 3 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 178 | 24 | 3 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 178 | 24 | 3 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 178 | 24 | 3 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 179 | 24 | 3 | 0b6731d9554f8bed1899c165a50e6b329ea19a6d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 182 | 24 | 3 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 182 | 24 | 3 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 184 | 24 | 3 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 184 | 24 | 3 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 24 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 24 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 188 | 24 | 3 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 188 | 24 | 3 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 189 | 24 | 3 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 189 | 24 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 189 | 24 | 3 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 189 | 24 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.41e-04 | 190 | 24 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-04 | 191 | 24 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 192 | 24 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 192 | 24 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 192 | 24 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 192 | 24 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 192 | 24 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 193 | 24 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.47e-04 | 193 | 24 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-04 | 193 | 24 | 3 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.47e-04 | 193 | 24 | 3 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.47e-04 | 193 | 24 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 194 | 24 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.49e-04 | 194 | 24 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.49e-04 | 194 | 24 | 3 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.52e-04 | 195 | 24 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.52e-04 | 195 | 24 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.52e-04 | 195 | 24 | 3 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 196 | 24 | 3 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.56e-04 | 197 | 24 | 3 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.59e-04 | 198 | 24 | 3 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | 306e28d31fd587409a12dcccc6b2abd7dc9c2e0a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.59e-04 | 198 | 24 | 3 | 77c81ec602ab553a544c3d9b1e66181b6f000d12 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-04 | 198 | 24 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.59e-04 | 198 | 24 | 3 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | 05429f18e1d74880c1835568c86177f661b3477a | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.61e-04 | 199 | 24 | 3 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | c59f262b2b0a7e7dcb2940d1e466f98db6c56625 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | e50ef394e3284a8323bfd60575b262b2be422aea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| Disease | susceptibility to cold sores measurement | 1.17e-03 | 65 | 23 | 2 | EFO_0008402 | |
| Disease | vital capacity | 2.29e-03 | 1236 | 23 | 5 | EFO_0004312 | |
| Disease | osteoarthritis, hip | 2.33e-03 | 92 | 23 | 2 | EFO_1000786 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 2.48e-03 | 95 | 23 | 2 | EFO_0803331 | |
| Disease | forced expiratory volume | 3.00e-03 | 789 | 23 | 4 | EFO_0004314 | |
| Disease | facial morphology measurement | 5.48e-03 | 466 | 23 | 3 | EFO_0007841 | |
| Disease | myeloid white cell count | 5.53e-03 | 937 | 23 | 4 | EFO_0007988 | |
| Disease | colorectal cancer, colorectal adenoma | 6.21e-03 | 152 | 23 | 2 | EFO_0005406, MONDO_0005575 | |
| Disease | dyslexia | 7.03e-03 | 162 | 23 | 2 | EFO_0005424 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKPSPAPYKSRRSPL | 231 | Q2T9L4 | |
| PAPARAFKVKPPHGF | 461 | Q96JM7 | |
| HVKGKSYPFRGPFPP | 91 | P27338 | |
| GSARRPRPPCAKPHK | 51 | Q6PKG0 | |
| KPRKAPSTSHSGFPP | 561 | Q66K74 | |
| PPTPKESPHFYRKGT | 446 | Q9HDC5 | |
| GPHGPSPKKFYPRFT | 46 | Q8NCW6 | |
| YTGSFKKPPLRRPHS | 61 | Q00537 | |
| APLSFIPRHFRPKGA | 221 | Q6WN34 | |
| GPYSPKKRPHFPALK | 191 | Q96BT1 | |
| RSDGKNFSPPPFPRK | 51 | Q86Z20 | |
| PSSPAAPRPASKKHF | 946 | Q8NF50 | |
| PFINPLPKPRRTFKH | 261 | Q9ULE3 | |
| PVKPSRPKRHFSSAG | 121 | Q6ZU35 | |
| KRFTRKPSPKPTFGP | 21 | Q8NCU4 | |
| LPHRPRPFSPGKQAS | 61 | P22003 | |
| DPFHSLKRPRPPFAR | 1431 | Q5VT52 | |
| SRPPPHYPGIKRKRS | 191 | O75923 | |
| PPPAPDKKHARHFSL | 501 | Q96RD6 | |
| KKHRPPGPLFSSSDP | 276 | A6NNC1 | |
| REPQSRKEPHKPPFF | 286 | Q9UPX6 | |
| CPPLFKPSHPQKRFA | 611 | Q75VX8 | |
| PGTPPHKTFRKLRLF | 171 | P30291 | |
| KFKAHFPPRGPPRSS | 346 | Q5VX71 | |
| RLPPHPKYPDGKTFT | 461 | Q96SK2 |